Cargando…
Outcome of SARS-CoV-2 infection in patients with severe asthma on biologics
Autores principales: | Kagohashi, Katsunori, Miyazaki, Kunihiko, Satoh, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936774/ https://www.ncbi.nlm.nih.gov/pubmed/33722436 http://dx.doi.org/10.1016/j.rmed.2021.106358 |
Ejemplares similares
-
Long-term safety of budesonide/formoterol for the treatment of elderly patients with bronchial asthma
por: KAGOHASHI, KATSUNORI, et al.
Publicado: (2014) -
Polymorphonuclear-rich and lymphocyte-rich tuberculous pleural effusion
por: Okauchi, Shinichiro, et al.
Publicado: (2020) -
Neurologic Features in Severe SARS-CoV-2 Infection
por: Helms, Julie, et al.
Publicado: (2020) -
Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections
por: Abu-Raddad, Laith J., et al.
Publicado: (2021) -
Prediction of Neurodevelopmental Outcomes in SARS-CoV-2 Infections
por: Madaan, Priyanka, et al.
Publicado: (2021)